US 11571412
Thromboxane receptor antagonists in AERD/asthma
granted A61KA61K31/422A61K31/616
Quick answer
US patent 11571412 (Thromboxane receptor antagonists in AERD/asthma) held by Cumberland Pharmaceuticals Inc. expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/422, A61K31/616, A61P, A61P11/00